Epidemiological Analysis From 2018 to 2020 in China and Prevention Strategy of Porcine Circovirus Type 2

Porcine circovirus type 2 (PCV2) is one of the smallest known animal viruses and is the main pathogen of PCV-associated diseases (PCVAD). Epidemiological surveillance results have shown that the PCV2 infection rate is on the rise in China, thus, PCV2 disease prevention and control has become a huge...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ying Huang, Xianghong Chen, Yunzhi Long, Liu Yang, Wenbo Song, Jinjin Liu, Qianqian Li, Gong Liang, Daobing Yu, Chao Huang, Xibiao Tang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/9b639998f03b49b6b5e7d3a45e752733
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9b639998f03b49b6b5e7d3a45e752733
record_format dspace
spelling oai:doaj.org-article:9b639998f03b49b6b5e7d3a45e7527332021-11-16T04:58:17ZEpidemiological Analysis From 2018 to 2020 in China and Prevention Strategy of Porcine Circovirus Type 22297-176910.3389/fvets.2021.753297https://doaj.org/article/9b639998f03b49b6b5e7d3a45e7527332021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fvets.2021.753297/fullhttps://doaj.org/toc/2297-1769Porcine circovirus type 2 (PCV2) is one of the smallest known animal viruses and is the main pathogen of PCV-associated diseases (PCVAD). Epidemiological surveillance results have shown that the PCV2 infection rate is on the rise in China, thus, PCV2 disease prevention and control has become a huge challenge for the Chinese swine industry. We collected clinical samples from multiple different provinces in China from 2018 to 2020 and found that the positive rate of PCV2 was 53% (3619/6872), identity between the cloned 62 ORF2 genes was 84.4–100% and identity between the cloned 62 ORF2 sequences and reference sequence was 72.9–99.8%. Genetic evolution analysis found that PCV2d accounted for 79% (49/62 samples), PCV2a for 12.9% (8/62 samples), PCV2b for 8% (5/62 samples), and PCV2c and PCV2e genotypes were not found. However, most commercial PCV2 subunit vaccines are based on the PCV2a genotype, and there are very few vaccines based on PCV2b or PCV2d. Therefore, the homologous and heterologous protection ability of PCV2b and PCV2d Cap proteins based on the baculovirus against the PCV2b and PCV2d infections was evaluated, which is expected to design and develop excellent PCV2 protein vaccine candidates. This study found that both PCV2b and PCV2d Cap proteins can increase the level of humoral immunity and cellular immune response in mice. Importantly, both PCV2b and PCV2d cap proteins can provide homologous and heterologous protection against the PCV2b and PCV2d viruses. Overall, this study provides a reference for the prevention and control of PCVAD in mainland China and the development of PCV2 vaccines.Ying HuangXianghong ChenYunzhi LongLiu YangWenbo SongJinjin LiuQianqian LiGong LiangDaobing YuChao HuangXibiao TangFrontiers Media S.A.articleepidemiological analysisPCV2b CapPCV2d Caphomologous protectionheterologous protectionVeterinary medicineSF600-1100ENFrontiers in Veterinary Science, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic epidemiological analysis
PCV2b Cap
PCV2d Cap
homologous protection
heterologous protection
Veterinary medicine
SF600-1100
spellingShingle epidemiological analysis
PCV2b Cap
PCV2d Cap
homologous protection
heterologous protection
Veterinary medicine
SF600-1100
Ying Huang
Xianghong Chen
Yunzhi Long
Liu Yang
Wenbo Song
Jinjin Liu
Qianqian Li
Gong Liang
Daobing Yu
Chao Huang
Xibiao Tang
Epidemiological Analysis From 2018 to 2020 in China and Prevention Strategy of Porcine Circovirus Type 2
description Porcine circovirus type 2 (PCV2) is one of the smallest known animal viruses and is the main pathogen of PCV-associated diseases (PCVAD). Epidemiological surveillance results have shown that the PCV2 infection rate is on the rise in China, thus, PCV2 disease prevention and control has become a huge challenge for the Chinese swine industry. We collected clinical samples from multiple different provinces in China from 2018 to 2020 and found that the positive rate of PCV2 was 53% (3619/6872), identity between the cloned 62 ORF2 genes was 84.4–100% and identity between the cloned 62 ORF2 sequences and reference sequence was 72.9–99.8%. Genetic evolution analysis found that PCV2d accounted for 79% (49/62 samples), PCV2a for 12.9% (8/62 samples), PCV2b for 8% (5/62 samples), and PCV2c and PCV2e genotypes were not found. However, most commercial PCV2 subunit vaccines are based on the PCV2a genotype, and there are very few vaccines based on PCV2b or PCV2d. Therefore, the homologous and heterologous protection ability of PCV2b and PCV2d Cap proteins based on the baculovirus against the PCV2b and PCV2d infections was evaluated, which is expected to design and develop excellent PCV2 protein vaccine candidates. This study found that both PCV2b and PCV2d Cap proteins can increase the level of humoral immunity and cellular immune response in mice. Importantly, both PCV2b and PCV2d cap proteins can provide homologous and heterologous protection against the PCV2b and PCV2d viruses. Overall, this study provides a reference for the prevention and control of PCVAD in mainland China and the development of PCV2 vaccines.
format article
author Ying Huang
Xianghong Chen
Yunzhi Long
Liu Yang
Wenbo Song
Jinjin Liu
Qianqian Li
Gong Liang
Daobing Yu
Chao Huang
Xibiao Tang
author_facet Ying Huang
Xianghong Chen
Yunzhi Long
Liu Yang
Wenbo Song
Jinjin Liu
Qianqian Li
Gong Liang
Daobing Yu
Chao Huang
Xibiao Tang
author_sort Ying Huang
title Epidemiological Analysis From 2018 to 2020 in China and Prevention Strategy of Porcine Circovirus Type 2
title_short Epidemiological Analysis From 2018 to 2020 in China and Prevention Strategy of Porcine Circovirus Type 2
title_full Epidemiological Analysis From 2018 to 2020 in China and Prevention Strategy of Porcine Circovirus Type 2
title_fullStr Epidemiological Analysis From 2018 to 2020 in China and Prevention Strategy of Porcine Circovirus Type 2
title_full_unstemmed Epidemiological Analysis From 2018 to 2020 in China and Prevention Strategy of Porcine Circovirus Type 2
title_sort epidemiological analysis from 2018 to 2020 in china and prevention strategy of porcine circovirus type 2
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/9b639998f03b49b6b5e7d3a45e752733
work_keys_str_mv AT yinghuang epidemiologicalanalysisfrom2018to2020inchinaandpreventionstrategyofporcinecircovirustype2
AT xianghongchen epidemiologicalanalysisfrom2018to2020inchinaandpreventionstrategyofporcinecircovirustype2
AT yunzhilong epidemiologicalanalysisfrom2018to2020inchinaandpreventionstrategyofporcinecircovirustype2
AT liuyang epidemiologicalanalysisfrom2018to2020inchinaandpreventionstrategyofporcinecircovirustype2
AT wenbosong epidemiologicalanalysisfrom2018to2020inchinaandpreventionstrategyofporcinecircovirustype2
AT jinjinliu epidemiologicalanalysisfrom2018to2020inchinaandpreventionstrategyofporcinecircovirustype2
AT qianqianli epidemiologicalanalysisfrom2018to2020inchinaandpreventionstrategyofporcinecircovirustype2
AT gongliang epidemiologicalanalysisfrom2018to2020inchinaandpreventionstrategyofporcinecircovirustype2
AT daobingyu epidemiologicalanalysisfrom2018to2020inchinaandpreventionstrategyofporcinecircovirustype2
AT chaohuang epidemiologicalanalysisfrom2018to2020inchinaandpreventionstrategyofporcinecircovirustype2
AT xibiaotang epidemiologicalanalysisfrom2018to2020inchinaandpreventionstrategyofporcinecircovirustype2
_version_ 1718426742872342528